Stock Events

Stock Events

Alnylam Pharmaceuticals (A1LN34.SA) Q3 2021 Earnings

3AugConfirmed

Q4 2020

Q1 2021

Q2 2021

Q3 2021

-12.04

-10.82

-9.59

-8.37

Details

Expected EPS

-8.57472

Actual EPS

-8.366848

Surprise EPS

0.21

Surprise Percent

+2.42%

Description

Alnylam Pharmaceuticals (A1LN34.SA) has reported earnings of -8.366848 per share for Q3 2021.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.